CD2AP and kidney disorder: However, it did not significantly reduce the increased expression of fibronectin, further increased the expression of LEF1, upregulated PAI-1 (Figure 8, CD2AP−/−+tankyrase inhibitor), a fibrogenic factor that has been associated with the development of nephropathy,41 and increased pro-apoptotic signaling.